Newbury Pharmaceuticals ABStockholm
LEI 549300F7XHU3I8CWL373 · XSTO · SE · Business ID 559274-2463
Recent insider sentiment
No open-market buying or selling — last 90 days
Share-award batches are excluded from this read — they’re compensation, not conviction.
0
Open-market buys (90d)
0
Sales (90d)
0
Share awards (90d)
0
Active insiders (90d)
Transactions
| Date | Person | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 18.11.2025 | Alsakali Equity AB — CEO | Bought — open marketAcquisition | 25,859 | SEK 1.59 | SEK 41,115.81 | ↗ |
| 17.11.2025 | Alsakali Equity AB — CEO | Bought — open marketAcquisition | 67,855 | SEK 1.39 | SEK 94,318.45 | ↗ |
| 12.11.2025 | Alsakali Equity AB — CEO | Bought — open marketAcquisition | 20,000 | SEK 1.91 | SEK 38,172.00 | ↗ |
Active insiders (90d)
No activity in the last 90 days.